Mammalian Foregut and Liver Development

哺乳动物前肠和肝脏发育

基本信息

  • 批准号:
    8204678
  • 负责人:
  • 金额:
    $ 36.09万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-01-01 至 2013-12-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT The long-term goal of this proposal is to elucidate the molecular mechanism controlling mammalian foregut and early liver development. The largest exocrine gland in the body the liver produces bile and is the primary site for detoxification. It also performs important endocrine functions by secreting homeostatic blood proteins and regulating glucose levels through glycogen storage. A recent trans-NIH report "Action Plan for Liver Disease Research (2004)" recognized that a better understanding of embryonic liver development would provide important insights into human liver disease and promote our ability to harness embryonic stem cells as a renewable source of tissue for transplantation. The mouse embryonic liver is induced from the ventral foregut endoderm by Fgf signals from the cardiac mesoderm. While we increasingly understand the genetic pathways regulating proliferation and differentiation of hepatoblasts after the liver bud has formed, the earlier events linking endoderm patterning to hepatic specification are less clear. In Xenopus we recently determined that differential Wnt/¿eta-catenin signaling regulates endoderm fates. Our data supports a model where during gastrula and early somite stages secreted Wnt- antagonists in the anterior endoderm establish foregut identity and initiate a molecular cascade leading to liver development. In contrast, the posterior endoderm has high ¿eta-catenin activity, due to Wnt ligands secreted from the lateral/axial mesoderm, which represses foregut fate and promotes intestinal development. We propose to test this hypothesis using mouse genetics and embryonic explants to characterize the underlying molecular mechanism. Moreover, we will investigate whether analogous pathways are important for liver development in humans using endoderm cultures derived from human embryonic stem cells. The results of this proposal will directly impact efforts to generate therapeutically useful endoderm tissue for the treatment of liver disease in humans. Aim 1. Determine if repression of ¿eta-catenin activity in the anterior endoderm is required for foregut and liver development using mouse genetics. Aim 2. Define when ¿eta-catenin needs to be repressed and examine how the temporally distinct Wnt and Fgf pathways interact during hepatic development, using mouse embryonic explant cultures. Aim 3. Investigate the role of Wnt signaling in promoting human foregut and liver lineages from HESCs
摘要

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Building additional complexity to in vitro-derived intestinal tissues.
  • DOI:
    10.1186/scrt362
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    7.5
  • 作者:
    Brugmann SA;Wells JM
  • 通讯作者:
    Wells JM
Generation of β cells from human pluripotent stem cells: are we there yet?
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James M Wells其他文献

ヒトiPS細胞由来膵島オルガノイドのサイズ制御による効率的な分化誘導
通过控制人 iPS 细胞来源的胰岛类器官的大小进行有效分化诱导
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    浅見柚羽;草森浩輔;西川元也;James M Wells
  • 通讯作者:
    James M Wells
Mechanism and in vitro reconstruction of mammalian trachea-esophageal development
哺乳动物气管食管发育机制及体外重建
  • DOI:
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Lu Han;Praneet Chaturvedi;Keishi Kishimoto;Hiroyuki Koike;Talia Nasr;Kentaro Iwasawa;Kirsten Giesbrecht;Phillip C Witcher;Alexandra Eicher;Lauren Haines;Yarim Lee;John M Shannon;Mitsuru Morimoto;James M Wells;Takanori Takebe;Aaron M Zorn;Keishi Kishimoto
  • 通讯作者:
    Keishi Kishimoto

James M Wells的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James M Wells', 18)}}的其他基金

Project-3: Modeling EA/TEF in human organoids
项目 3:在人体类器官中模拟 EA/TEF
  • 批准号:
    10458162
  • 财政年份:
    2017
  • 资助金额:
    $ 36.09万
  • 项目类别:
Modeling esophageal/respiratory birth defects in human pluripotent stem cell (PSC)-derived fetal tissues
在人类多能干细胞 (PSC) 衍生的胎儿组织中模拟食管/呼吸系统出生缺陷
  • 批准号:
    10174986
  • 财政年份:
    2017
  • 资助金额:
    $ 36.09万
  • 项目类别:
Project-3: Modeling EA/TEF in human organoids
项目 3:在人体类器官中模拟 EA/TEF
  • 批准号:
    10647838
  • 财政年份:
    2017
  • 资助金额:
    $ 36.09万
  • 项目类别:
Human Endocrine Cell Development
人类内分泌细胞发育
  • 批准号:
    8814212
  • 财政年份:
    2012
  • 资助金额:
    $ 36.09万
  • 项目类别:
Generating Human Intestinal Organoids with an ENS.
使用 ENS 生成人类肠道类器官。
  • 批准号:
    8415736
  • 财政年份:
    2012
  • 资助金额:
    $ 36.09万
  • 项目类别:
Generating Human Intestinal Organoids with an ENS.
使用 ENS 生成人类肠道类器官。
  • 批准号:
    8516139
  • 财政年份:
    2012
  • 资助金额:
    $ 36.09万
  • 项目类别:
Generating Human Intestinal Organoids with an ENS.
使用 ENS 生成人类肠道类器官。
  • 批准号:
    8665593
  • 财政年份:
    2012
  • 资助金额:
    $ 36.09万
  • 项目类别:
Mammalian Foregut and Liver Development
哺乳动物前肠和肝脏发育
  • 批准号:
    7895193
  • 财政年份:
    2009
  • 资助金额:
    $ 36.09万
  • 项目类别:
Mammalian Foregut and Liver Development
哺乳动物前肠和肝脏发育
  • 批准号:
    7753860
  • 财政年份:
    2009
  • 资助金额:
    $ 36.09万
  • 项目类别:
Mammalian Foregut and Liver Development
哺乳动物前肠和肝脏发育
  • 批准号:
    7582986
  • 财政年份:
    2009
  • 资助金额:
    $ 36.09万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了